Size Exclusion Chromatography of Biosimilar and Innovator Insulin
نویسنده
چکیده
Insulin is a small polypeptide hormone that controls blood glucose homeostasis. Genetic engineering techniques have enabled biopharma companies to develop diverse, long-acting insulin analogs. There is no pharmacopeia method available for the analysis of insulin analogs. An SEC method identifying innovator and biosimilar insulin analog, following a draft EP method, was developed using an Agilent AdvanceBio SEC 130 Å, 7.8 × 300 mm, 2.7 μm column. The effectiveness of this method, for routine analysis, was confi rmed using a system suitability test, and retention time (RT) and area precision studies using innovator insulin as a reference material. This Application Note also presents the application of this column for detecting impurities with molecular masses greater than that of insulin for quantitation studies.
منابع مشابه
Charge Variants of an Avastin Biosimilar Isolation, Characterization, In Vitro Properties and Pharmacokinetics in Rat
The similarity between a proposed biosimilar product and the reference product can be affected by many factors. This study is designed to examine whether any subtle difference in the distribution of the charge variants of an Avastin biosimilar can affect its in vitro potency and in vivo PK. Here, the acidic, basic and main peak fractions of a biosimilar product were isolated using high-performa...
متن کاملPeptide Mapping of Innovator and Biosimilar Monoclonal Antibody Using an Agilent 1290 Infinity UHPLC Coupled to an Agilent 6550 iFunnel Q-TOF LC/MS System
Monoclonal antibodies (mAbs) are becoming one of the important classes of biomolecules for the treatment of various cancers. Biosimilar mAbs, which are the replica of the licensed innovator product in the market are also gaining lots of attention. According to the FDA definition1, “Biosimilars are a type of biological product that are licensed (approved) by FDA because they are highly similar t...
متن کاملOrganic matter from biofilter nitrification by high performance size exclusion chromatography and fluorescence excitation-emission matrix
A combination of high performance size exclusion chromatography with organic carbon detector and ultraviolet detector coupled with peak-fitting technique and fluorescence excitation-emission matrix spectrometry applied fluorescence regional integration method was conducted to determine the characteristics of organic matter during nitrification. The batch scale of bionet nitrification without or...
متن کاملBiosimilars to treat inflammatory arthritis: the challenge of proving identity.
The introduction of targeted biological therapies has revolutionised the treatment of patients with inflammatory joint diseases. These medications are highly effective in reducing disease activity, improving physical function, and retarding or arresting the progression of structural damage. Their relative benefits and risks have been ascertained and contraindications to their use are well known...
متن کاملPharmacokinetic Comparability of a Biosimilar Trastuzumab Anticipated from Its Physicochemical and Biological Characterization
Comparability between a biosimilar and its reference product requires the evaluation of critical quality attributes that may impact on its pharmacological response. Herein we present a physicochemical characterization of a biosimilar trastuzumab focused on the attributes related to the pharmacokinetic response. Capillary isoelectrofocusing (cIEF) and cation exchange chromatography (CEX) were us...
متن کامل